Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
JH-021 in Advanced Malignant Solid Neoplasm: NCT07582822 Clinical Landscape Report 2026
16 October 2026
NCT07582822 clinical landscape for Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Tirzepatide in Diabetes Mellitus, Type 2: NCT07588438 Clinical Landscape Report 2026
16 October 2026
NCT07588438 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
177Lu-SNA028 in Colorectal Cancer: NCT07590856 Clinical Landscape Report 2026
16 October 2026
NCT07590856 clinical landscape for Colorectal Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Olmesartan Medoxomil in Diabetes Mellitus, Type 2: NCT07590466 Clinical Landscape Report 2026
16 October 2026
NCT07590466 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ivonescimab in Non-small cell lung cancer stage II: NCT07594522 Clinical Landscape Report 2026
16 October 2026
NCT07594522 clinical landscape for Non-small cell lung cancer stage II: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
Ivonescimab in Advanced Lung Non-Small Cell Carcinoma: NCT07590531 Clinical Landscape Report 2026
16 October 2026
NCT07590531 clinical landscape for Advanced Lung Non-Small Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
AMG-127 in Diabetes Mellitus, Type 2: NCT07590193 Clinical Landscape Report 2026
16 October 2026
NCT07590193 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
S-531011 in MSS/pMMR/MSI-L Colorectal Carcinoma: NCT07591597 Clinical Landscape Report 2026
16 October 2026
NCT07591597 clinical landscape for MSS/pMMR/MSI-L Colorectal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
EB-DUO-CAR-NK-CEA/GCC in Advanced Colorectal Adenocarcinoma: NCT07589517 Clinical Landscape Report 2026
16 October 2026
NCT07589517 clinical landscape for Advanced Colorectal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
Paclitaxel in Non-Small Cell Lung Cancer: NCT07599163 Clinical Landscape Report 2026
16 October 2026
NCT07599163 clinical landscape for Non-Small Cell Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dapagliflozin in Diabetes Mellitus, Type 2: NCT07595289 Clinical Landscape Report 2026
16 October 2026
NCT07595289 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
68Ga-SNA009 in Colorectal Cancer: NCT07597759 Clinical Landscape Report 2026
16 October 2026
NCT07597759 clinical landscape for Colorectal Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.